Potential treatment strategy for Angelman syndrome identified by Philpot, Zylka and Roth
December 21, 2011
December 2011 - Collaborators Ben Philpot, Mark Zylka and Bryan Roth identify compounds that cause the dormant Ube3a gene to be expressed.
